Both in Surgical Instruments
NeuroOne Medical Technologies vs Femasys
Over the past year NMTC returned −79.3% and FEMY returned −89.7%; their daily moves had a correlation of 0.00.
NMTC −79.3% FEMY −89.7%Growth of $1, one year, split-adjusted
| Metric | NMTC | FEMY |
|---|---|---|
| Price | $0.9489 | $1.36 |
| Market cap | $8.6M | $11.4M |
| Today | +1.51% | +3.03% |
| 1 month | −14.9% | −32.7% |
| 6 months | −78.6% | −83.0% |
| Year to date | −79.1% | −88.2% |
| 1 year | −80.0% | −89.3% |
| Revenue growth (YoY) | +16.3% | −18.9% |
| Gross margin | 59.9% | 57.1% |
| Net margin | −101.7% | −1346.8% |
| P/E (TTM) | — | — |
| Price / sales | 0.7× | 5.0× |
| Net cash | $2.0M | -$2.1M |
| Dividend yield | — | — |
| Volatility (60d) | 98.7% | 90.2% |
| Short % of float | 2.8% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).